Hotline: +86-18022463983    020-85206863

United States Growth Hormone Deficiency Treatment Market Report & Forecast 2021-2027

Published Date: 2021-11-12   |   Pages: 94   |   Tables: 104   |  Medical Care

This report contains market size and forecasts of Growth Hormone Deficiency Treatment in United States, including the following market information:

United States Growth Hormone Deficiency Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

United States top five Growth Hormone Deficiency Treatment companies in 2020 (%)

The global Growth Hormone Deficiency Treatment market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The United States Growth Hormone Deficiency Treatment market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Growth Hormone Deficiency Treatment Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

United States Growth Hormone Deficiency Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Growth Hormone Deficiency Treatment Market Segment Percentages, By Type, 2020 (%)

Pharmacological Therapy

Recombinant Human Growth Hormone

Human Pituitary Gland Extracts

United States Growth Hormone Deficiency Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Growth Hormone Deficiency Treatment Market Segment Percentages, By Application, 2020 (%)

Hospitals

Clinics

Home Care Settings

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Growth Hormone Deficiency Treatment revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Growth Hormone Deficiency Treatment revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Sandoz International

Sanofi Aventis

Pfizer

Novo Nordisk

Teva Pharmaceutical

Ranbaxy

EMD Serono

Sun Pharmaceutical

Eli Lilly

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 Growth Hormone Deficiency Treatment Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 United States Growth Hormone Deficiency Treatment Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 United States Growth Hormone Deficiency Treatment Overall Market Size

2.1 United States Growth Hormone Deficiency Treatment Market Size: 2021 VS 2027

2.2 United States Growth Hormone Deficiency Treatment Revenue, Prospects & Forecasts: 2016-2027

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Growth Hormone Deficiency Treatment Players in United States Market

3.2 Top United States Growth Hormone Deficiency Treatment Companies Ranked by Revenue

3.3 United States Growth Hormone Deficiency Treatment Revenue by Companies

3.4 Top 3 and Top 5 Growth Hormone Deficiency Treatment Companies in United States Market, by Revenue in 2020

3.5 Companies Growth Hormone Deficiency Treatment Product Type

3.6 Tier 1, Tier 2 and Tier 3 Growth Hormone Deficiency Treatment Players in United States Market

3.6.1 List of Tier 1 Growth Hormone Deficiency Treatment Companies in United States

3.6.2 List of Tier 2 and Tier 3 Growth Hormone Deficiency Treatment Companies in United States

4 Sights by Type

4.1 Overview

4.1.1 By Type - United States Growth Hormone Deficiency Treatment Market Size Markets, 2021 & 2027

4.1.2 Pharmacological Therapy

4.1.3 Recombinant Human Growth Hormone

4.1.4 Human Pituitary Gland Extracts

4.2 By Type - United States Growth Hormone Deficiency Treatment Revenue & Forecasts

4.2.1 By Type - United States Growth Hormone Deficiency Treatment Revenue, 2016-2021

4.2.2 By Type - United States Growth Hormone Deficiency Treatment Revenue, 2022-2027

4.2.3 By Type - United States Growth Hormone Deficiency Treatment Revenue Market Share, 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - United States Growth Hormone Deficiency Treatment Market Size, 2021 & 2027

5.1.2 Hospitals

5.1.3 Clinics

5.1.4 Home Care Settings

5.2 By Application - United States Growth Hormone Deficiency Treatment Revenue & Forecasts

5.2.1 By Application - United States Growth Hormone Deficiency Treatment Revenue, 2016-2021

5.2.2 By Application - United States Growth Hormone Deficiency Treatment Revenue, 2022-2027

5.2.3 By Application - United States Growth Hormone Deficiency Treatment Revenue Market Share, 2016-2027

6 Growth Hormone Deficiency Treatment Companies Profiles

6.1 Sandoz International

6.1.1 Sandoz International Company Details

6.1.2 Sandoz International Business Overview

6.1.3 Sandoz International Growth Hormone Deficiency Treatment Introduction

6.1.4 Sandoz International Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.1.5 Sandoz International Recent Developments

6.2 Sanofi Aventis

6.2.1 Sanofi Aventis Company Details

6.2.2 Sanofi Aventis Business Overview

6.2.3 Sanofi Aventis Growth Hormone Deficiency Treatment Introduction

6.2.4 Sanofi Aventis Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.2.5 Sanofi Aventis Recent Developments

6.3 Pfizer

6.3.1 Pfizer Company Details

6.3.2 Pfizer Business Overview

6.3.3 Pfizer Growth Hormone Deficiency Treatment Introduction

6.3.4 Pfizer Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.3.5 Pfizer Recent Developments

6.4 Novo Nordisk

6.4.1 Novo Nordisk Company Details

6.4.2 Novo Nordisk Business Overview

6.4.3 Novo Nordisk Growth Hormone Deficiency Treatment Introduction

6.4.4 Novo Nordisk Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.4.5 Novo Nordisk Recent Developments

6.5 Teva Pharmaceutical

6.5.1 Teva Pharmaceutical Company Details

6.5.2 Teva Pharmaceutical Business Overview

6.5.3 Teva Pharmaceutical Growth Hormone Deficiency Treatment Introduction

6.5.4 Teva Pharmaceutical Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.5.5 Teva Pharmaceutical Recent Developments

6.6 Ranbaxy

6.6.1 Ranbaxy Company Details

6.6.2 Ranbaxy Business Overview

6.6.3 Ranbaxy Growth Hormone Deficiency Treatment Introduction

6.6.4 Ranbaxy Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.6.5 Ranbaxy Recent Developments

6.7 EMD Serono

6.7.1 EMD Serono Company Details

6.7.2 EMD Serono Business Overview

6.7.3 EMD Serono Growth Hormone Deficiency Treatment Introduction

6.7.4 EMD Serono Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.7.5 EMD Serono Recent Developments

6.8 Sun Pharmaceutical

6.8.1 Sun Pharmaceutical Company Details

6.8.2 Sun Pharmaceutical Business Overview

6.8.3 Sun Pharmaceutical Growth Hormone Deficiency Treatment Introduction

6.8.4 Sun Pharmaceutical Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.8.5 Sun Pharmaceutical Recent Developments

6.9 Eli Lilly

6.9.1 Eli Lilly Company Details

6.9.2 Eli Lilly Business Overview

6.9.3 Eli Lilly Growth Hormone Deficiency Treatment Introduction

6.9.4 Eli Lilly Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021)

6.9.5 Eli Lilly Recent Developments

7 Conclusion

8 Appendix

8.1 Note

8.2 Examples of Clients

8.3 Author Details

8.4 Disclaimer

List of Tables

Table 1. Growth Hormone Deficiency Treatment Market Opportunities & Trends in United States Market

Table 2. Growth Hormone Deficiency Treatment Market Drivers in United States Market

Table 3. Growth Hormone Deficiency Treatment Market Restraints in United States Market

Table 4. Key Players of Growth Hormone Deficiency Treatment in United States Market

Table 5. Top Growth Hormone Deficiency Treatment Players in United States Market, Ranking by Revenue (2019)

Table 6. United States Growth Hormone Deficiency Treatment Revenue by Companies, (US$, Mn), 2016-2021

Table 7. United States Growth Hormone Deficiency Treatment Revenue Share by Companies, 2016-2021

Table 8. Companies Growth Hormone Deficiency Treatment Product Type

Table 9. List of Tier 1 Growth Hormone Deficiency Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 Growth Hormone Deficiency Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. By Type – United States Growth Hormone Deficiency Treatment Revenue, (US$, Mn), 2021 & 2027

Table 12. By Type - United States Growth Hormone Deficiency Treatment Revenue (US$, Mn), 2016-2021

Table 13. By Type - United States Growth Hormone Deficiency Treatment Revenue (US$, Mn), 2022-2027

Table 14. By Application – United States Growth Hormone Deficiency Treatment Revenue, (US$, Mn), 2021 VS 2027

Table 15. By Application - United States Growth Hormone Deficiency Treatment Revenue (US$, Mn), 2016-2021

Table 16. By Application - United States Growth Hormone Deficiency Treatment Revenue (US$, Mn), 2022-2027

Table 17. Sandoz International Company Details

Table 18. Sandoz International Business Overview

Table 19. Sandoz International Growth Hormone Deficiency Treatment Product

Table 20. Sandoz International Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 21. Sandoz International Recent Developments

Table 22. Sanofi Aventis Company Details

Table 23. Sanofi Aventis Business Overview

Table 24. Sanofi Aventis Growth Hormone Deficiency Treatment Product

Table 25. Sanofi Aventis Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 26. Sanofi Aventis Recent Developments

Table 27. Pfizer Company Details

Table 28. Pfizer Business Overview

Table 29. Pfizer Growth Hormone Deficiency Treatment Product

Table 30. Pfizer Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 31. Pfizer Recent Developments

Table 32. Novo Nordisk Company Details

Table 33. Novo Nordisk Business Overview

Table 34. Novo Nordisk Growth Hormone Deficiency Treatment Product

Table 35. Novo Nordisk Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 36. Novo Nordisk Recent Developments

Table 37. Teva Pharmaceutical Company Details

Table 38. Teva Pharmaceutical Business Overview

Table 39. Teva Pharmaceutical Growth Hormone Deficiency Treatment Product

Table 40. Teva Pharmaceutical Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 41. Teva Pharmaceutical Recent Developments

Table 42. Ranbaxy Company Details

Table 43. Ranbaxy Business Overview

Table 44. Ranbaxy Growth Hormone Deficiency Treatment Product

Table 45. Ranbaxy Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 46. Ranbaxy Recent Developments

Table 47. EMD Serono Company Details

Table 48. EMD Serono Business Overview

Table 49. EMD Serono Growth Hormone Deficiency Treatment Product

Table 50. EMD Serono Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 51. EMD Serono Recent Developments

Table 52. Sun Pharmaceutical Company Details

Table 53. Sun Pharmaceutical Business Overview

Table 54. Sun Pharmaceutical Growth Hormone Deficiency Treatment Product

Table 55. Sun Pharmaceutical Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 56. Sun Pharmaceutical Recent Developments

Table 57. Eli Lilly Company Details

Table 58. Eli Lilly Business Overview

Table 59. Eli Lilly Growth Hormone Deficiency Treatment Product

Table 60. Eli Lilly Growth Hormone Deficiency Treatment Revenue in United States Market (2016-2021) & (US$ Million)

Table 61. Eli Lilly Recent Developments

List of Figures

Figure 1. Growth Hormone Deficiency Treatment Segment by Type

Figure 2. Growth Hormone Deficiency Treatment Segment by Application

Figure 3. United States Growth Hormone Deficiency Treatment Market Overview: 2020

Figure 4. United States Growth Hormone Deficiency Treatment Market Size: 2021 VS 2027 (US$, Mn)

Figure 5. United States Growth Hormone Deficiency Treatment Revenue, 2016-2027 (US$, Mn)

Figure 6. The Top 3 and 5 Players Market Share by Growth Hormone Deficiency Treatment Revenue in 2020

Figure 7. By Type - United States Growth Hormone Deficiency Treatment Revenue Market Share, 2016-2027

Figure 8. By Application - United States Growth Hormone Deficiency Treatment Revenue Market Share, 2016-2027

Figure 9. Sandoz International Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 10. Sanofi Aventis Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 11. Pfizer Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 12. Novo Nordisk Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 13. Teva Pharmaceutical Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 14. Ranbaxy Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 15. EMD Serono Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 16. Sun Pharmaceutical Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 17. Eli Lilly Growth Hormone Deficiency Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Our Clients